Save time and get answers to complex questions with AI chat
How does iron rich food intake impact lipitor's efficacy?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Guselkumab brand name?Abbvie humira patent cliff navigation success?When will latisse patent expire?
See the DrugPatentWatch profile for Syfovre
Syfovre (pegcetacoplan) received FDA approval on May 17, 2023.[1]
Syfovre was approved for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD) in adults.[1]
DrugPatentWatch.com maintains drug coverage that includes regulatory timelines such as approvals.[1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Syfovre :